Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin III in uremia.

K A Jørgensen, E Stoffersen

    Scandinavian Journal of Urology and Nephrology
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Antithrombin III (AT-III) levels are elevated in uremic patients, particularly those not on dialysis. Higher AT-III correlates with lower serum creatinine and albumin, suggesting albumin may aid AT-III and heparin function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients.

    Diabetic medicine : a journal of the British Diabetic Association·2012
    Same author

    Abnormal diurnal rhythm of urine output following renal transplantation: the impact of blood pressure and diuretics.

    Transplantation proceedings·2010
    Same author

    Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells.

    British journal of pharmacology·2010
    Same author

    Gene expression analysis of calcineurin isoforms in T-lymphocytes--a method applied on kidney-transplant recipients.

    Transplant immunology·2010
    Same author

    A combined experimental and theoretical study on realizing and using laser controlled torsion of molecules.

    The Journal of chemical physics·2009
    Same author

    NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease.

    Clinical nephrology·2009
    Same journal

    Fine Needle Biopsy of Metastases at Retrograde Pyelography, Directed by Fluoroscopy.

    Scandinavian journal of urology and nephrology·2017
    Same journal

    Mucinous Adenocarcinoma of the Prostate Presenting as a Retrovesical Cyst.

    Scandinavian journal of urology and nephrology·2016
    Same journal

    A Pilot Study of Metabolic Effects of Intravenously Given Alpha-Calcidol In Patients With Chronicc Renal Failure.

    Scandinavian journal of urology and nephrology·2016
    Same journal

    Seventh Report on the Standardisation of Terminology of Lower Urinary Tract Function: Lower Urinary Tract Rehabilitation Techniques.

    Scandinavian journal of urology and nephrology·2016
    Same journal

    Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.

    Scandinavian journal of urology and nephrology·2012
    Same journal

    Initial symptoms and delay in patients with penile carcinoma.

    Scandinavian journal of urology and nephrology·2012
    See all related articles

    Area of Science:

    • Nephrology
    • Hematology
    • Clinical Chemistry

    Background:

    • Uremia, a condition of kidney dysfunction, can affect various blood parameters.
    • Antithrombin III (AT-III) is a key regulator of coagulation.
    • Understanding AT-III levels in uremia is crucial for managing complications.

    Purpose of the Study:

    • To measure Antithrombin III (AT-III) levels in patients with uremia.
    • To investigate the relationship between AT-III levels and markers of kidney function and dialysis.
    • To explore potential correlations between AT-III, serum albumin, and heparin requirements.

    Main Methods:

    • Immunological measurement of Antithrombin III (AT-III).
    • Study included 20 uremic patients on maintenance hemodialysis and 10 non-dialyzed uremic patients.

    Related Experiment Videos

  • Analysis of correlations between AT-III, serum creatinine, serum albumin, and heparin dosage.

    • Main Results:

    • Dialyzed uremic patients showed slightly elevated AT-III levels.
    • Non-dialyzed uremic patients exhibited significantly elevated AT-III levels.
    • Negative correlations were observed between AT-III and serum creatinine, and AT-III and serum albumin. Heparin requirement correlated negatively with serum albumin.

    Conclusions:

    • Elevated AT-III levels are associated with uremia, particularly in non-dialyzed patients.
    • Serum albumin may play a role in facilitating the action of AT-III and heparin.
    • AT-III levels might indicate active renal disease, potentially decreasing as uremia progresses.